211 related articles for article (PubMed ID: 7916907)
1. Exposure of anionic phospholipids upon platelet activation permits binding of beta 2 glycoprotein I and through it that of IgG antiphospholipid antibodies. Studies in platelets from patients with antiphospholipid syndrome and normal subjects.
Vázquez-Mellado J; Llorente L; Richaud-Patin Y; Alarcón-Segovia D
J Autoimmun; 1994 Jun; 7(3):335-48. PubMed ID: 7916907
[TBL] [Abstract][Full Text] [Related]
2. Immunologic characterization and functional properties of murine antibodies raised against deleted mutants of human beta 2-glycoprotein I.
George J; Blank M; Gilburd B; Hojnik M; Shenkman B; Tamarin I; Varon D; Matsuura E; Koike T; Shoenfeld Y
Int Immunol; 1997 Jun; 9(6):913-21. PubMed ID: 9199975
[TBL] [Abstract][Full Text] [Related]
3. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
Arnout J
Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
[TBL] [Abstract][Full Text] [Related]
4. Some 'antiphospholipid antibodies' bind to beta 2-glycoprotein I in the absence of phospholipid.
Keeling DM; Wilson AJ; Mackie IJ; Machin SJ; Isenberg DA
Br J Haematol; 1992 Nov; 82(3):571-4. PubMed ID: 1486037
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune antiphospholipid antibodies are directed against a cryptic epitope expressed when beta 2-glycoprotein I is bound to a suitable surface.
Pengo V; Biasiolo A; Fior MG
Thromb Haemost; 1995 Jan; 73(1):29-34. PubMed ID: 7537919
[TBL] [Abstract][Full Text] [Related]
6. A new player in the antiphospholipid syndrome: the beta 2 glycoprotein I cofactor.
Valesini G; Shoenfeld Y
Autoimmunity; 1992; 14(2):105-10. PubMed ID: 1303677
[TBL] [Abstract][Full Text] [Related]
7. Antiphospholipid antibodies differ in aPL cofactor requirement.
Sammaritano LR; Lockshin MD; Gharavi AE
Lupus; 1992 Feb; 1(2):83-90. PubMed ID: 1301968
[TBL] [Abstract][Full Text] [Related]
8. IgG from patients with antiphospholipid syndrome binds to platelets without induction of platelet activation.
Ford I; Urbaniak S; Greaves M
Br J Haematol; 1998 Aug; 102(3):841-9. PubMed ID: 9722315
[TBL] [Abstract][Full Text] [Related]
9. Lupus anticoagulant activity of autoimmune antiphospholipid antibodies is dependent upon beta 2-glycoprotein I.
Roubey RA; Pratt CW; Buyon JP; Winfield JB
J Clin Invest; 1992 Sep; 90(3):1100-4. PubMed ID: 1522218
[TBL] [Abstract][Full Text] [Related]
10. Phospholipid specificity and requirement of beta 2-glycoprotein-I for reactivity of antibodies from patients with primary antiphospholipid syndrome.
Cabral AR; Cabiedes J; Alarcón-Segovia D; Sánchez-Guerrero J
J Autoimmun; 1992 Dec; 5(6):787-801. PubMed ID: 1489489
[TBL] [Abstract][Full Text] [Related]
11. Effect of anticardiolipin/beta2-glycoprotein I complexes on production of thromboxane A2 by platelets from patients with the antiphospholipid syndrome.
Robbins DL; Leung S; Miller-Blair DJ; Ziboh V
J Rheumatol; 1998 Jan; 25(1):51-6. PubMed ID: 9458202
[TBL] [Abstract][Full Text] [Related]
12. Changes in beta 2-glycoprotein I antigenicity induced by phospholipid binding.
Wagenknecht DR; McIntyre JA
Thromb Haemost; 1993 Apr; 69(4):361-5. PubMed ID: 7684533
[TBL] [Abstract][Full Text] [Related]
13. [Antiphospholipid and anti beta 2-glycoprotein I antibodies].
Arvieux J; Roussel B; Colomb MG
Ann Biol Clin (Paris); 1994; 52(5):381-5. PubMed ID: 7856939
[TBL] [Abstract][Full Text] [Related]
14. Antiphospholipid antibodies and thrombosis.
Brighton TA; Chesterman CN
Baillieres Clin Haematol; 1994 Sep; 7(3):541-57. PubMed ID: 7841600
[TBL] [Abstract][Full Text] [Related]
15. Anti-beta 2-glycoprotein I antibodies: a useful marker for the antiphospholipid syndrome.
Teixidó M; Font J; Reverter JC; Cervera R; Tàssies D; Ingelmo M; Escolar G; Ordinas A
Br J Rheumatol; 1997 Jan; 36(1):113-6. PubMed ID: 9117149
[TBL] [Abstract][Full Text] [Related]
16. Lupus anticoagulant activity of some antiphospholipid antibodies against phospholipid bound beta 2 glycoprotein I.
Keeling DM; Wilson AJ; Mackie IJ; Isenberg DA; Machin SJ
J Clin Pathol; 1993 Jul; 46(7):665-7. PubMed ID: 8157757
[TBL] [Abstract][Full Text] [Related]
17. Anti-cardiolipin antibody from a patient with antiphospholipid syndrome (APS) recognizes only an epitope expressed by cardiolipin/beta 2-glycoprotein-I (beta 2GPI) complex and induces APS.
Levy Y; Sherer Y; Mathieu A; Cauli A; Passiu G; Sanna G; Janackovic Z; Blank M; Shoenfeld Y
Clin Exp Rheumatol; 2000; 18(4):479-84. PubMed ID: 10949723
[TBL] [Abstract][Full Text] [Related]
18. Anti beta 2 glycoprotein I antibodies: detection and association with thrombosis.
Martinuzzo ME; Forastiero RR; Carreras LO
Br J Haematol; 1995 Feb; 89(2):397-402. PubMed ID: 7873391
[TBL] [Abstract][Full Text] [Related]
19. Standardization of immunoassays for antiphospholipid antibodies with beta 2GPI and role of other phospholipid cofactors.
Amiral J; Larrivaz I; Cluzeau D; Adam M
Haemostasis; 1994; 24(3):191-203. PubMed ID: 7527366
[TBL] [Abstract][Full Text] [Related]
20. Human beta 2-glycoprotein I binds to endothelial cells through a cluster of lysine residues that are critical for anionic phospholipid binding and offers epitopes for anti-beta 2-glycoprotein I antibodies.
Del Papa N; Sheng YH; Raschi E; Kandiah DA; Tincani A; Khamashta MA; Atsumi T; Hughes GR; Ichikawa K; Koike T; Balestrieri G; Krilis SA; Meroni PL
J Immunol; 1998 Jun; 160(11):5572-8. PubMed ID: 9605162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
